Cardiac Arrest With Successful Resuscitation
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Colorado TherapeuticsCO - Louisville
1 programDecision Aid for Surrogate Decision Makers of Comatose Survivors of Cardiac ArrestN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Colorado TherapeuticsDecision Aid for Surrogate Decision Makers of Comatose Survivors of Cardiac Arrest
BrainCoolIQool
Clinical Trials (2)
Total enrollment: 79 patients across 2 trials
NCT03908346Colorado TherapeuticsDecision Aid for Surrogate Decision Makers of Comatose Survivors of Cardiac Arrest
A Novel Patient Decision Aid for Surrogate Decision Makers of Comatose Survivors of Cardiac Arrest
Start: Jul 2020Est. completion: Dec 202241 patients
N/ACompleted
Study of Brain Cools Device in Patients Resuscitated From Cardiac Arrest
Start: May 2019Est. completion: Dec 202138 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.